Scholars Central

EditorialPublished 18 Mar 2022

Editorial Note on Plasma Cell Leukemia

Authors: Cesar Alfredo Pena Ramos

Journal of Leukemia

Volume 10 · Issue 4 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Plasma Cell Leukemia (PCL) is a plasma cell dyscrasia, for example an infection including the harmful degeneration of a subtype of white platelets called plasma cells. It is the terminal stage and most forceful type of these dyscrasias, establishing 2%to 4% of all instances of plasma cell malignancies. PCL might present as essential plasma cell leukemia, for example in patients without earlier history of a plasma cell dyscrasia or as auxiliary plasma cell dyscrasia, for example in patients recently determined to have a background marked by its archetype dyscrasia, different myeloma [1]. The two types of PCL seem, by all accounts, to be unquestionably somewhat unmistakable from one another. In all cases, notwithstanding, PCL is a very genuine, dangerous, and remedially testing illness [2].

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Leukemia.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Leukemia
  • SubjectHaematology
  • BylineArticles whose byline prints “Cesar Alfredo Pena Ramos”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels